Novo Nordisk has requested the FDA to dam creation of compounded copies of copyright, arguing that it’s much too tough to do safely. It’s the latest escalation inside of a brewing war amongst pharmaceutical organizations and compounders.Ron Gershoni, co-founding father of vape producer Jetty Extracts, who sits to the board of the California Can